Tata Capital Healthcare Raises Equity Fund Of Rs 955 Cr

Tata Capital Healthcare Fund II (TCHF II), sponsored by Tata Capital, has closed its fund with investor commitments of Rs 955 crore, meeting its target AUM of Rs 950 crore (excluding green-shoe). This was a follow-up to the Tata Capital Healthcare Fund I which had raised Rs 411 crore in 2012.

TCHF II has received commitments from domestic and international financial and strategic institutions including some of the global pharma, medical equipment companies, development financial institutions and large European Institutions indicating their support for the TCHF investment strategy. TCHF II has also received commitment from the ‘Self Reliant India (SRI)’ Fund of the Government of India under the Ministry of Micro, Small and Medium Enterprises.

“TCHF II will seek to achieve returns by principally taking equity positions in healthcare and life sciences-related companies having significant business exposure to India. We remain grateful and would like to thank our investors for reposing faith and trust in the Tata Capital Healthcare Fund franchise,” said Visalakshi Chandramouli, Managing Partner, TCHF.

The over USD 190 billion Indian healthcare and life sciences market is estimated to grow at a compounded annual growth rate (CAGR) of 14 per cent over the next five years and it represents an attractive investment opportunity. Indian healthcare and life sciences market is the second fastest-growing market in the world. India’s population of over 1.3 billion people provides a strong demand driver as there is a significant mismatch between supply and demand in the healthcare and life sciences sector. This supply-demand mismatch, combined with the world class skill sets of India’s healthcare and pharmaceutical professionals, make the healthcare and life sciences sector a compelling investment opportunity.